Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era

Patients with inflammatory bowel disease (IBD) are at an increased risk of developing intestinal neoplasia—particularly colorectal neoplasia, including dysplasia and colorectal cancer (CRC)—as a primary consequence of chronic inflammation. While the current incidence of CRC in IBD is lower compared...

Full description

Bibliographic Details
Main Authors: Jordan E. Axelrad, Shailja C. Shah
Format: Article
Language:English
Published: SAGE Publishing 2020-05-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756284820920779
_version_ 1819278597899157504
author Jordan E. Axelrad
Shailja C. Shah
author_facet Jordan E. Axelrad
Shailja C. Shah
author_sort Jordan E. Axelrad
collection DOAJ
description Patients with inflammatory bowel disease (IBD) are at an increased risk of developing intestinal neoplasia—particularly colorectal neoplasia, including dysplasia and colorectal cancer (CRC)—as a primary consequence of chronic inflammation. While the current incidence of CRC in IBD is lower compared with prior decades, due, in large part, to more effective therapies and improved colonoscopic technologies, CRC still accounts for a significant proportion of IBD-related deaths. The focus of this review is on the pathogenesis; epidemiology, including disease- and patient-related risk factors; diagnosis; surveillance; and management of IBD-associated neoplasia.
first_indexed 2024-12-24T00:14:33Z
format Article
id doaj.art-29fc2ccb6a744386b2cf7e1ad3e2775e
institution Directory Open Access Journal
issn 1756-2848
language English
last_indexed 2024-12-24T00:14:33Z
publishDate 2020-05-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Gastroenterology
spelling doaj.art-29fc2ccb6a744386b2cf7e1ad3e2775e2022-12-21T17:24:46ZengSAGE PublishingTherapeutic Advances in Gastroenterology1756-28482020-05-011310.1177/1756284820920779Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern eraJordan E. AxelradShailja C. ShahPatients with inflammatory bowel disease (IBD) are at an increased risk of developing intestinal neoplasia—particularly colorectal neoplasia, including dysplasia and colorectal cancer (CRC)—as a primary consequence of chronic inflammation. While the current incidence of CRC in IBD is lower compared with prior decades, due, in large part, to more effective therapies and improved colonoscopic technologies, CRC still accounts for a significant proportion of IBD-related deaths. The focus of this review is on the pathogenesis; epidemiology, including disease- and patient-related risk factors; diagnosis; surveillance; and management of IBD-associated neoplasia.https://doi.org/10.1177/1756284820920779
spellingShingle Jordan E. Axelrad
Shailja C. Shah
Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
Therapeutic Advances in Gastroenterology
title Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
title_full Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
title_fullStr Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
title_full_unstemmed Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
title_short Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
title_sort diagnosis and management of inflammatory bowel disease associated neoplasia considerations in the modern era
url https://doi.org/10.1177/1756284820920779
work_keys_str_mv AT jordaneaxelrad diagnosisandmanagementofinflammatoryboweldiseaseassociatedneoplasiaconsiderationsinthemodernera
AT shailjacshah diagnosisandmanagementofinflammatoryboweldiseaseassociatedneoplasiaconsiderationsinthemodernera